摘要 |
The invention provides 2, 3-, 4- or 5-substituted-N1-(arylsulfonyl)indole and (heteroaryl)indole compounds of the general formula (I): in which Ar, R<SUP>2</SUP>, R<SUP>3</SUP>, R<SUP>4 </SUP>and R<SUP>5 </SUP>are as defined in the specification. The compounds bind to the 5-HT<SUB>6 </SUB>receptor and are useful for the treatment and prophylaxis of disorders mediated by the 5-HT<SUB>6 </SUB>receptor, such as obesity and CNS disorders.
|